Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension

European Heart Journal

Volumn 30, Issue 24, 2009, Pages 3048-3054

  Gkaliagkousi, Eugenia ^a   Corrigall, Valerie ^a   Becker, Silke ^a   De Winter, Patricia ^a   Shah, Ashish ^a   Zamboulis, Chrysanthos ^b   Ritter, James ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Blood pressure; Monocyte platelet aggregates; Monocytes; Nitric oxide; Platelets

Indexed keywords

ARGININE; CYCLIC GMP; EXBB PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN;

ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION;

ADULT; ARGININE; BLOOD PLATELETS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MONOCYTES; NITRIC OXIDE; P-SELECTIN; PLATELET AGGREGATION; SIGNAL TRANSDUCTION;

EID: 72649083963     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp330     Document Type: Article

References (26)

1. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986;78: 130-137.
2. Freedman JE, Li L, Sauter R, Keaney JJ. Alpha-tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. FASEB J 2000;14: 2377-2379.
3. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-554.
4. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003;9:61-67.
5. da Costa Martins P, van den Berk N, Ulfman LH, Koenderman L, Hordijk PL, Zwaginga JJ. Platelet-monocyte complexes support monocyte adhesion to endo-thelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 2004;24:193-199.
6. Woods JD, Edwards JS, Ritter JM. Inhibition by nitroprusside of platelet calcium mobilization: evidence for reduced sensitivity to nitric oxide in essential hypertension. J Hypertens 1993;11:1369-1373.
7. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the
8. Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004, 44, 415-422.
9. Nityanand S, Pande I, Bajpai VK, Singh L, Chandra M, Singh BN. Platelets in essential hypertension. Thromb Res 1993;72:447-454.
10. 2- Adrenoceptors activate nitric oxide synthase in human platelets. Circ Res 2000;87:39-44.
11. Radomski MD, Palmer MJR, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87:5193-5197.
12. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keany JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100:350-356.
13. Chung AW, Radomski A, Alonso-Escolano D, Jurasz P, Stewart MW, Malinski T, Radomski MW. Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. Br J Pharmacol 2004;143: 845-855.
14. Goubareva I, Gkaliagkousi E, Shah A, Queen L, Ritter J, Ferro A. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. Cardiovasc Res 2007;75:793-802.
15. Wahbi N, Dalton RN, Turner C, Denton M, Abbs I, Swaminathan R. Dimethylar-ginines in chronic renal failure. J Clin Pathol 2001;54:470-473.
16. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-298.
17. Parmentier S, Bohme GA, Lerouet D, Damour D, Stutzmann JM, Margaill I, Plotkine M. Selective inhibition of inducible nitric oxide synthase prevents ischae-mic brain injury. Br J Pharmacol 1999;127:546-552.
18. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997;272:4959-4963.
19. Labios M, Martinez M, Gabriel F, Guiral V, Munoz A, Aznar J. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension. Am J Hypertens 2004;17:757-763.
20. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 2003;83:183-252.
21. Chen LY, Mehta JL. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol 1998;32:57-61.
22. Kang ES, Ford K, Grokulsky G, Wang YB, Chiang TM, Acchiardo SR. Normal circulating adult human red blood cells contain inactive NOS proteins. J Lab Clin Med 2000;135:444-451.
23. Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minuz P, Manzato F, Tridente G, Lechi A. Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens 1996;14:1215-1221.
24. Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, throm-bogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997;80:1566-1571.
25. Ji Y, Ferracci G, Warley A, Ward M, Leung KY, Samsuddin S, Lévěque C, Queen L, Reebye V, Pal P, Gkaliagkousi E, Seager M, Ferro A. Beta-actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90. Proc Natl Acad Sci USA 2007;104:8839-8844.
26. Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 2007;101:654-662.